NCT01012414View on ClinicalTrials.gov

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Coronary Artery DiseaseChronic Kidney DiseaseHypovitaminosis DSecondary Hyperparathyroidism
Interventions
DRUG

paricalcitol

2 mcg oral paricalcitol daily

DRUG

placebo

placebo

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Thomas Jefferson University

OTHER

NCT01012414 - Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter